Cobalt Serum Level as a Biomarker of Cause-Specific Survival among Prostate Cancer Patients.
biomarker
cobalt
prostate cancer
survival
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
23 Jul 2024
23 Jul 2024
Historique:
received:
31
05
2024
revised:
15
07
2024
accepted:
20
07
2024
medline:
10
8
2024
pubmed:
10
8
2024
entrez:
10
8
2024
Statut:
epublish
Résumé
Prostate cancer is the most common cancer diagnosed in men and the second leading cause of death in male cancer patients. The WHO suggests that cobalt is involved in the carcinogenesis of prostate cancer. There are, however, no studies associating cobalt levels and prostate cancer patient survival. In this study, 261 Polish prostate cancer (
Identifiants
pubmed: 39123346
pii: cancers16152618
doi: 10.3390/cancers16152618
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Program of the Minister of Science and Higher Education called the "Regional Excellence In-itiative" in 2019-2023
ID : 002/RID/2018/19